- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07943130
Exploring the Interplay Between Maternal Stress, Human Milk, and Epigenetic Changes in Preterm Infant's Neurodevelopment (EMBRACE)
Preterm birth represents a major challenge in pediatric healthcare, as preterm infants are at increased risk of neonatal complications and long-term neurodevelopmental impairments. Several factors may contribute to these outcomes, including gestational age at birth, postnatal comorbidities, and the neonatal intensive care unit (NICU) environment. Furthermore, preterm birth and prolonged hospitalization may negatively affect maternal psychological well-being, increasing the risk of stress, anxiety, and depression. These conditions may influence maternal sensitivity and responsiveness, mother-infant interactions, and infant neurodevelopment.
Emerging evidence suggests that maternal mental health may affect infant neurodevelopment through both direct biological mechanisms, such as epigenetic regulation, and indirect pathways, including changes in breast milk composition. Cortisol, a stress-related hormone present in breast milk and saliva, may play a role in stress regulation and neurobehavioral development. In particular, the methylation of Long Interspersed Nuclear Element-1 (LINE-1 or L1), a mobile genetic element involved in genomic regulation, may be influenced by environmental factors and early maternal care. Preliminary findings indicate that preterm infants exhibit lower L1 promoter methylation levels at birth than term infants, while early maternal care may modulate these levels and support neurobehavioral development.
The EMBRACE study aims primarily to investigate the relationship between biological maternal stress, measured through salivary cortisol levels, and L1 promoter methylation in blood samples collected from preterm infants from birth to 12 months of corrected age. Secondary objectives include examining this relationship in buccal swab samples, assessing associations between maternal perceived stress, anxiety, and depression and infant L1 methylation, and investigating the relationship between maternal psychological and biological stress indicators and infant neurodevelopmental outcomes. The study will also explore associations between perceived maternal stress and cortisol concentrations in breast milk and saliva, as well as longitudinal changes in L1 methylation.
This is a non-pharmacological, observational cohort study conducted at the Neonatology and Neonatal Intensive Care Unit of the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico in Milan, Italy. Participants will include preterm infants born between 24+0 and 30+6 weeks of gestational age and their mothers. Assessments will be conducted at five time points: birth, transition to intermediate care or 34 weeks of postmenstrual age, hospital discharge, 6 months, and 12 months of corrected age. Maternal assessments will include standardized questionnaires evaluating stress, anxiety, and depression, as well as cortisol measurements in saliva and breast milk. Infant assessments will include L1 methylation analyses in blood and buccal samples and standardized neurodevelopmental evaluations as part of routine clinical follow-up. No additional invasive procedures will be performed, as blood samples will be collected during routine clinical care.
The study is expected to improve understanding of the relationships between maternal stress, anxiety, depression, epigenetic regulation, and neurodevelopment in preterm infants. It will also investigate the potential role of breast milk cortisol in these associations. Ultimately, the findings may contribute to the development of early interventions aimed at improving neurodevelopmental outcomes in preterm infants and supporting maternal psychological well-being.
Aperçu de l'étude
Statut
Les conditions
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Camilla Fontana
- Numéro de téléphone: 0255032951
- E-mail: camilla.fontana@unimi.it
Lieux d'étude
-
-
Lombardy
-
Milan, Lombardy, Italie, 20122
- Recrutement
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
-
Contact:
- Camilla Fontana
- Numéro de téléphone: +390255032951
- E-mail: camilla.fontana@unimi.it
-
Sous-enquêteur:
- Chiara Bonfanti
-
Sous-enquêteur:
- Agnese De Carli
-
Sous-enquêteur:
- Monica Fumagalli
-
Sous-enquêteur:
- Mary Giorgia Gaccione
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
All preterm infants born at the SC Neonatologia e Terapia Intensiva Neonatale - Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano and their mothers.
La description
Inclusion Criteria:
- Preterm infants born between 24+0 and 30+6 weeks of gestational age (GA);
- Mothers aged ≥ 18 years with adequate understanding of the Italian language;
- Signed informed consent from parents.
Exclusion Criteria:
- Parents decline participation;
- Infants with major congenital anomalies, malformations, or genetic syndromes;
- Mothers with obvious psychiatric conditions, cognitive deficits, or active substance abuse at the time of delivery.
- Infants birth samples not available (both buccal swab and blood)
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: COHORT
- Perspectives temporelles: PROSPECTIVE
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Epigenetic changes on LINE1 (blood samples)
Délai: up to 48 weeks post menstrual age
|
epigenetic analysis is performed on cord blood samples collected at birth, at transition to intermediate care and at hospital discharge on peripheral blood samples |
up to 48 weeks post menstrual age
|
|
Maternal salivary cortisol
Délai: up to 12 months corrected age of the infant
|
Collected at birth, transition to intermediate care, discharge |
up to 12 months corrected age of the infant
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Human milk cortisol concentrations
Délai: up to 6 months corrected age of the infant
|
Collected at birth, transition to intermediate care, discharge |
up to 6 months corrected age of the infant
|
|
Buccal swab
Délai: up to 12 months corrected age
|
Collected at birth, 34 weeks GA, discharge, 6 and 12 months corrected age |
up to 12 months corrected age
|
|
Neurological outcome
Délai: up to 44 weeks post menstrual age
|
Hammersmith neonatal neurological examination performed at NICU discharge |
up to 44 weeks post menstrual age
|
|
Neonatal Visual Assessment
Délai: up to 44 weeks post menstrual age
|
Neonatal visual function in assessed at discharge using the Visual Assessment battery developed by Ricci et al. The assessment has 9 items and each one is scored as normal or abnormal according to the description given by the authors. |
up to 44 weeks post menstrual age
|
|
Neonatal behavior
Délai: up to 44 weeks post menstrual age
|
Neonatal behavior is assessed using the Neonatal Behavior Assessment Scale, and in particular the areas of state organization, state regulation, and the autonomic system. Each item will be scored according to the description given by the author of the assessment |
up to 44 weeks post menstrual age
|
|
Neurodevelopmental outcome
Délai: from 6 to 12 months corrected age
|
Bayley scales to assess neurodevelopment at 6 and 12 months corrected age. The normal range for the composite score is 100 +/- 15 points. Higher scores mean better outcomes. |
from 6 to 12 months corrected age
|
|
Maternal depression
Délai: up to 12 months corrected age of the infant
|
Assessed with the Edinburgh Postnatal depression scale. Responses are scored 0 to 3. A score above 8 is considered pathological in the post partum period. It will be administered at birth, at transition to intermediate care, at NICu discharge at 6 and 12 months corrected age. |
up to 12 months corrected age of the infant
|
|
Maternal stress in the NICU
Délai: up to 12 months corrected age of the infant
|
Assessed with the Parental Stressor Scale: Neonatal Intensive Care Unit (PSS:NICU). It is composed of 35 items that are scored on a 5-point Likert scale ranging from 1 (not stressful at all) to 5 (extremely stressfull). It will be administered at birth, at transition to intermediate care and at NICu discharge. |
up to 12 months corrected age of the infant
|
|
Maternal bonding
Délai: up to 12 months corrected age of the infant
|
Assessed with the Postpartum Bonding Questionnaire (PBQ) administered at NICU discharge, 6 and 12 months corrected age. A score above 26 is considered pathological. |
up to 12 months corrected age of the infant
|
|
Maternal anxiety and depression
Délai: up to 12 months corrected age of the infant
|
Assessed with the hospital anxiety and depression scale (HAD-S). It will be administered at birth, at transition to intermediate care, at NICu discharge at 6 and 12 months corrected age. A score from 0 to 7 is normal, 8-10 borderline and 11-21 score in the clinical range. |
up to 12 months corrected age of the infant
|
|
Parenting stress
Délai: up to 12 months corrected age of the infant
|
Assessed with the Parenting Stress Index Scale. Administered at 6 and 12 months corrected age. It is composed of 36 items that are scored on a 5-point Likert scale ranging from 1 (not stressful at all) to 5 (extremely stressful) |
up to 12 months corrected age of the infant
|
Collaborateurs et enquêteurs
Collaborateurs
Publications et liens utiles
Publications générales
- Bedrosian TA, Quayle C, Novaresi N, Gage FH. Early life experience drives structural variation of neural genomes in mice. Science. 2018 Mar 23;359(6382):1395-1399. doi: 10.1126/science.aah3378.
- Pace CC, Spittle AJ, Molesworth CM, Lee KJ, Northam EA, Cheong JL, Davis PG, Doyle LW, Treyvaud K, Anderson PJ. Evolution of Depression and Anxiety Symptoms in Parents of Very Preterm Infants During the Newborn Period. JAMA Pediatr. 2016 Sep 1;170(9):863-70. doi: 10.1001/jamapediatrics.2016.0810.
- Fontana C, Marasca F, Provitera L, Mancinelli S, Pesenti N, Sinha S, Passera S, Abrignani S, Mosca F, Lodato S, Bodega B, Fumagalli M. Early maternal care restores LINE-1 methylation and enhances neurodevelopment in preterm infants. BMC Med. 2021 Feb 5;19(1):42. doi: 10.1186/s12916-020-01896-0.
- Casavant SG, Cong X, Moore J, Starkweather A. Associations between preterm infant stress, epigenetic alteration, telomere length and neurodevelopmental outcomes: A systematic review. Early Hum Dev. 2019 Apr;131:63-74. doi: 10.1016/j.earlhumdev.2019.03.003. Epub 2019 Mar 11.
- Rosen-Carole CB, Greenman S, Wang H, Sonawane S, Misra R, O'Connor T, Jarvinen K, D'Angio C, Young BE. Association between maternal stress and premature milk cortisol, milk IgA, and infant health: a cohort study. Front Nutr. 2024 Mar 6;11:1270523. doi: 10.3389/fnut.2024.1270523. eCollection 2024.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- EMBRACE
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .